Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
The Prostate|January 1, 1984
Cytotoxic chemotherapeutic agents under development with a possible future role in prostate cancerP J CreavenBulletin Du Cancer|January 1, 1979
Pharmacokinetic parameters: potential for and problems with their use as predictors of response to cancer chemotherapeutic agentsP J CreavenCancer Research|December 15, 1993
In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatinL Pendyala, P J CreavenCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1995
Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trialL Pendyala, P J CreavenInternational Endodontic Journal|November 1, 1993
Antibacterial properties of eight dental cementsM M Coogan, P J CreavenJournal of the American Academy of Dermatology|May 11, 1991
Response to tumor necrosis factor in two cases of psoriasisP J Creaven, H L StollThe Journal of Prosthetic Dentistry|July 1, 1979
Evaluation of clinical methods for assessing the surface roughness of restorationsR J Smales, P J CreavenDrugs Under Experimental and Clinical Research|January 1, 1986
Clinical development of iproplatin (CHIP)P J Creaven, L Pendyala, S MadajewiczCancer Research|November 1, 1985
Effect of renal function impairment of iproplatin pharmacokinetics and relation to toxicityL Pendyala, S Madajewicz, P J CreavenInvestigational New Drugs|January 1, 1985
Human pharmacokinetics of 1-[2-[2-(4 pyridyl)-2-imidazolinyl-(1)]-ethyl]-3-(4-carboxyphenyl) urea (CGP 15720A)L Pendyala, S Madajewicz, P J CreavenPageof 12